DE3574251D1 - An anti-amnestic agent - Google Patents

An anti-amnestic agent

Info

Publication number
DE3574251D1
DE3574251D1 DE8585102668T DE3574251T DE3574251D1 DE 3574251 D1 DE3574251 D1 DE 3574251D1 DE 8585102668 T DE8585102668 T DE 8585102668T DE 3574251 T DE3574251 T DE 3574251T DE 3574251 D1 DE3574251 D1 DE 3574251D1
Authority
DE
Germany
Prior art keywords
amnestic agent
amnestic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585102668T
Other languages
English (en)
Inventor
Daisuke Tsuru
Tadashi Yoshimoto
Hisao Hagiwara
Kunio Kado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of DE3574251D1 publication Critical patent/DE3574251D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8585102668T 1984-03-09 1985-03-08 An anti-amnestic agent Expired DE3574251D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59043751A JPS60188317A (ja) 1984-03-09 1984-03-09 抗健忘症剤

Publications (1)

Publication Number Publication Date
DE3574251D1 true DE3574251D1 (en) 1989-12-21

Family

ID=12672465

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198585102668T Pending DE154353T1 (de) 1984-03-09 1985-03-08 Anti-gedaechtnisschwund-mittel.
DE8585102668T Expired DE3574251D1 (en) 1984-03-09 1985-03-08 An anti-amnestic agent

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE198585102668T Pending DE154353T1 (de) 1984-03-09 1985-03-08 Anti-gedaechtnisschwund-mittel.

Country Status (5)

Country Link
US (1) US4687778A (de)
EP (1) EP0154353B1 (de)
JP (1) JPS60188317A (de)
CA (1) CA1237987A (de)
DE (2) DE154353T1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651677B2 (ja) * 1985-12-23 1994-07-06 サントリー株式会社 ジペプチド誘導体及びその製法並びに用途
JPH0611754B2 (ja) * 1985-10-09 1994-02-16 サントリー株式会社 ペプチダ−ゼ阻害作用を有する新規化合物及びその製法並びに用途
JPH0623191B2 (ja) * 1985-04-16 1994-03-30 サントリー株式会社 ペプチダ−ゼ阻害活性化合物およびその製法ならびに用途
CA1309805C (en) * 1985-04-16 1992-11-03 Naoki Higuchi Dipeptide derivative and synthesis and use thereof
EP0201743B1 (de) * 1985-04-16 1992-04-01 Suntory Limited Dipeptid-Derivate von Fettsäure, Verfahren zu ihrer Herstellung, Heilmittel, das sie enthält und Anwendung
JPH0764834B2 (ja) * 1985-11-29 1995-07-12 サントリー株式会社 プロリルエンドペプチダーゼ阻害活性を有する新規ピロリジンアミド誘導体およびその製法並びに用途
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
US5198458A (en) * 1986-02-04 1993-03-30 Suntory Limited Pyrrolidineamide derivatives of acylamino acid and pharmaceutical composition containing the same
US4880827A (en) * 1986-03-18 1989-11-14 Sumitomo Pharmaceuticals Company, Ltd. Pyrrolidine derivatives having inhibitory action for proline specific endopepidase
JPH08806B2 (ja) * 1986-11-18 1996-01-10 サントリー株式会社 プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジンアミド誘導体
US5254550A (en) * 1986-11-20 1993-10-19 Ono Pharmaceutical Co., Ltd. Prolinal derivatives and pharmaceutical compositions thereof
EP0268190B1 (de) * 1986-11-20 1993-06-16 Ono Pharmaceutical Co., Ltd. Prolinalderivate
EP0277588B1 (de) * 1987-02-04 1993-03-24 Ono Pharmaceutical Co., Ltd. Prolinalderivate
DE3855875T2 (de) * 1987-02-23 1997-08-28 Ono Pharmaceutical Co Thiazolidin-Derivate
US5043348A (en) * 1987-04-24 1991-08-27 Cassella Aktiengesellschaft Pyrrolealdehydes, their preparation and their use
JP2515568B2 (ja) * 1987-12-25 1996-07-10 株式会社ヤクルト本社 新規なチアゾリジン誘導体
CA1335079C (en) * 1988-07-25 1995-04-04 Kiyoshi Takatsuki Preventive and curative agents for acquired immune deficiency syndrome (aids)
JP2691442B2 (ja) * 1989-02-20 1997-12-17 株式会社ヤクルト本社 新規なプロリン誘導体
EP0419683A4 (en) * 1989-04-13 1992-03-11 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5506256A (en) * 1990-07-27 1996-04-09 Yoshitomi Pharmaceutical Industries, Ltd. Proline derivatives possessing prolyl endopeptidase-inhibitory activity
US7667044B2 (en) 2003-11-03 2010-02-23 Probiodrug Ag Compounds for the treatment of neurological disorders
WO2006058720A2 (en) * 2003-11-03 2006-06-08 Probiodrug Ag Novel compounds for the treatment of neurological disorders
JP2008521853A (ja) * 2004-12-02 2008-06-26 プロビオドルグ エージー 神経疾患治療用の新規化合物

Also Published As

Publication number Publication date
CA1237987A (en) 1988-06-14
EP0154353A2 (de) 1985-09-11
EP0154353B1 (de) 1989-11-15
JPH0419208B2 (de) 1992-03-30
JPS60188317A (ja) 1985-09-25
DE154353T1 (de) 1986-04-10
EP0154353A3 (en) 1986-01-22
US4687778A (en) 1987-08-18

Similar Documents

Publication Publication Date Title
GB8614549D0 (en) Contrast agents
GB8613493D0 (en) Diester-dtpa-paramagnetic contrast agents
DE3574251D1 (en) An anti-amnestic agent
EP0181267A3 (en) Fibrinolysis-enhancing agents
GB8419086D0 (en) Components
GB8415105D0 (en) Sealing-curing agent
GB8529238D0 (en) Agents
BG45796A1 (en) Vibro- rammer
GB8400747D0 (en) Protrophic agent
AU2828584A (en) Cholagogic/cholelithotriptic agent
AU94917S (en) An upper-garment
CS543085A1 (en) Osova (axialni) turbina
CS190284A1 (en) Agent inhibiting xanthinreductases
AU92877S (en) Hose-box
BG38141A1 (en) Videoconverter
AU91199S (en) Tea-towel
AU91637S (en) Gamesboard
AU91905S (en) Nebulisor
AU92106S (en) Water-scrubbing-brush
AU92392S (en) Watertimer
AU92666S (en) Humidity-sensor
AU92711S (en) Attache-case
AU89905S (en) Flounce
AU94251S (en) Trailer-bicycle
AU95275S (en) Sun-shield

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee